Highest-materiality recent filing
DuPont announces 1-for-3 reverse stock split effective June 24, reaffirms 2026 guidance
Board approved 1-for-3 reverse stock split; effective 12:01 a.m. ET June 24, 2026; trading on split-adjusted basis same day on NYSE.
DuPont beats Q1 2026 guidance, raises full-year outlook; Aramids divestiture complete
Q1 net sales $1.7B +4% YoY; organic sales +2%; GAAP EPS $0.36, adjusted EPS $0.55.
DuPont expects to close aramids business sale to Arclin on April 1, 2026
All regulatory conditions for sale of Kevlar and Nomex business satisfied as of March 10, 2026.
DuPont Q4 GAAP loss $(0.27)/share but adj. EPS $0.46 beats; initiates FY2026 guide
Q4 net sales $1.7B flat, organic -1%; GAAP loss from cont. ops $(108)M vs. $(291)M year ago.
DuPont buys back $739M of 5.419% notes, amends indentures on two note series
Received requisite consents to amend indentures for 5.319% Notes due 2038 and 5.419% Notes due 2048; supplemental indenture effective Nov 19.
DuPont Q3 beats guidance; raises FY 2025 EBITDA forecast, unveils $2B buyback, $0.20 dividend
Q3 net sales $3.07B (+7% YoY); GAAP EPS $0.70; adjusted EPS $1.09; operating EBITDA $840M (+6%).
Completed spin-off of Electronics business as Qnity (Q); holders got 1 Q share per 2 DD shares.
DuPont completes Electronics spin-off; receives $4.1B from Qnity; plans $4.0B debt reduction
Separation completed Nov 1, 2025 via pro rata dividend of Qnity shares to DuPont shareholders.
DuPont board approves spin-off of Electronics business as Qnity; distribution set for Nov 1, 2025
Shareholders receive 1 Qnity share for every 2 DD shares held on record date Oct 22, 2025; distribution Nov 1.
DuPont targets Nov 1, 2025 for Electronics spin-off; Aramids sale for $1.8B
Electronics separation into Qnity targeted for November 1, 2025; no shareholder vote required.
DuPont sells Aramids business (Kevlar, Nomex) to Arclin for $1.8B
Transaction valued at ~$1.8B; DuPont to receive ~$1.2B cash, $300M note, and 17.5% equity stake in Arclin.
DuPont sells Aramids business to Arclin for ~$1.8B; expects Q1 2026 close
DuPont entered definitive agreement to sell Aramids (Kevlar, Nomex) to Arclin for ~$1.8B.
Qnity Electronics issues $1.75B in notes to fund DuPont spin-off cash distribution
Qnity issued $1.0B 5.750% senior secured notes due 2032 and $750M 6.250% senior unsecured notes due 2033.
DuPont subsidiary Qnity announces $2.5B debt offering for electronics spin-off
$1.5B senior secured notes due 2032 and $1.0B senior unsecured notes due 2033 offered.
DuPont Q2 2025: Adjusted EPS $1.12 (+15% YoY); raises full-year guidance
GAAP EPS from continuing ops $0.54; adjusted EPS $1.12, up 15% YoY; net sales $3.26B, +3%.
DuPont reaches $875M NJ environmental settlement, records $177M pre-tax charge
Aggregate $875M cash payment over 25 years to NJ; DuPont's share $311M NPV ($177M pre-tax charge in Q2 2025).
SAMR suspends antitrust investigation into DuPont's Tyvek business
China's SAMR suspended its antitrust investigation into DuPont's Tyvek business on July 22, 2025.
DuPont Q1 adj EPS $1.03 beats $0.79; net sales +6% organic; maintains FY guidance
Net sales $3.07B (+5% YoY, organic +6%); GAAP loss $(548)M from $768M goodwill impairment.
China's SAMR investigates DuPont's Tyvek business; sales to China ~$90M (<1% of total)
State Administration for Market Regulation launched an investigation into DuPont's Tyvek business.
DuPont Q4 net sales $3.09B (+7% YoY), adj EPS $1.13 (+30%); FY2025 guidance: adj EPS $4.30-4.40
Q4 net sales $3.09B (+7% YoY); GAAP loss from cont ops $(61)M, adj EPS $1.13 (vs $0.87, +30%).
DuPont Q3 net sales $3.19B (+4%), adj EPS $1.18 (+28%), raises FY2024 outlook
GAAP EPS from cont ops $1.13 vs $0.62 YoY; operating EBITDA $857M (+11%); margin 26.8% (+150bps).
DuPont Q2 net sales $3.2B (+2% YoY); raises FY2024 guidance for net sales, EBITDA and adj. EPS
GAAP EPS from cont. ops. $0.40, down 27% YoY; adjusted EPS $0.97, up 14% YoY.
DuPont plans to split into three independent companies; redeems $650M of 2038 notes
Separations into Electronics, Water, and diversified industrial 'new' DuPont expected within 18-24 months.
DuPont announces CEO transition and plan to split into three public companies
CEO Ed Breen becomes Executive Chairman; CFO Lori Koch becomes CEO, Antonella Franzen named CFO, effective June 1, 2024.
DuPont Q1 beats expectations, raises FY2024 guidance; organic sales down 6%
Net sales $2.93B (-3% reported, -6% organic); GAAP EPS $0.41, adj EPS $0.79 vs $0.84 YoY.
Q4 GAAP loss from continuing ops of $300M ($0.72 loss per share) includes $804M non-cash goodwill impairment.
DuPont prelim Q4 GAAP loss up to $370M; $750-850M goodwill impairment
Preliminary Q4 GAAP loss $(370)-(220)M; GAAP EPS $(0.88)-(0.52); adj. EPS $0.85-$0.87.
DuPont Q3 adjusted EPS $0.92 (+12% YoY) on rev $3.1B (-8%); cuts FY guidance
GAAP EPS from continuing ops $0.62, adjusted EPS $0.92; operating EBITDA $775M, margin 25.3%.
DuPont Q2 net sales $3.1B, -7% YoY; adj EPS $0.85 beats; Spectrum acquisition closed
GAAP income from continuing ops $269M ($0.55 EPS); adjusted EPS $0.85 vs $0.88 YoY.
DuPont, Chemours, Corteva settle PFAS water-system claims for $1.185B; DuPont takes $400M Q2 charge
DuPont to contribute ~$400M of total $1.185B settlement; pre-tax charge in Q2 2023.
DuPont, Chemours, Corteva agree to $1.185B PFAS drinking water settlement
Total settlement $1.185B cash; Chemours 50% (~$592M), DuPont ~$400M, Corteva ~$193M.
DuPont Q1 adj EPS $0.84 meets; cuts FY outlook; to buy Spectrum Plastics
Q1 net sales $3.02B, down 8% YoY; organic sales -3% (volume -7%, price +4%).
DuPont reports Q4 adjusted EPS $0.89 (+16% YoY); raises dividend 9% to $0.36/share
Q4 net sales $3.1B (-4% reported), organic sales +5%; GAAP EPS $0.20, adjusted EPS $0.89.
Mr. Leland G. Weaver, President of the Water & Protection segment will leave the Company.
On February 21, 2025, DuPont de Nemours, Inc. (the “Company”) appointed Kurt B. McMaken to its Board of Directors, effective immediately.
On and effective as of June 27, 2024, the Board of Directors (the “Board”) of DuPont de Nemours, Inc. (the “Company”) appointed Lori D. Koch, the Company’s Chief Executive Officer, to the Board of the Company.
Lori D. Koch, the Company’s Chief Financial Officer, will succeed Mr. Breen as Chief Executive Officer
Edward D. Breen will transition from the role of Chief Executive Officer to full-time Executive Chairman of the Company’s board of directors
Antonella B. Franzen is appointed Senior Vice President and Chief Financial Officer
Effective November 1, 2022, and in connection with the closing of the Transaction, Randy Stone, who served as President of DuPont Mobility & Materials, terminated employment with DuPont and transferred employment with the M&M Business to Buyer.
Franklin K. Clyburn, Jr. has tendered his resignation as a member of the Board of Directors of DuPont de Nemours, Inc. (the “Company”) effective January 20, 2022, in connection with his appointment as Chief Executive Officer and Director of International Flavors & Fragrances Inc. effective February 14, 2022.
On August 3, 2021, Rose Lee, President of the Water & Protection segment of DuPont de Nemours, Inc. (the “Company”) advised the Company of her resignation effective August 31, 2021.
Max materiality 0.90 · Median 0.70 · Most common event earnings